Myocardial ischemia and reperfusion result in endothelial and ventricular d
ysfunction. Beta-blockers protect the myocytes from injury by acting as ant
i-ischemia agents. These anti-ischemic effects of the beta-blockers are due
not only to their negative inotropic/chronotropic effects but also to a li
pid peroxidation reducing mechanism. Thus, beta-blockers enhance myocardial
recovery. In the present study 20 isolated guinea-pig hearts were perfused
with Krebs-Henseleit buffer (KHB) using a Langendorff apparatus. The anima
ls were allocated into 2 groups. In the study group (Group I), metoprolol,
as the beta-blocker agent, was added into the KHB and in the control group
(Group II) perfusion was performed without metoprolol. The percentage chang
e (%change) of heart rate, developed pressure and dP/dtmax; malondialdehyde
(MDA) and glutathione (GSH) levels of the perfusate and heart tissue were
obtained as data. The %change of heart rate was 70.5+/-9.2 in the study gro
up and 87.3+/-8.2 in the control (p=0.003). The %change of developed pressu
re was 68.7+/-14.4 and 55.9+/-8.6 in the study group and control group, res
pectively (p=0.04). The % change of dP/dt was 63.3+/-10.0 in the study grou
p and 54.4+/-5.3 in the control group (p=0.01). The tissue MDA level was 31
.0+/-5.5 nmol/g tissue in the study group and 53.5+/-4.2 nmol/g tissue in t
he control group (p=0.0002). The tissue GSH levels were 1.08+/-0.20 and 0.8
0+/-0.07 (mol/g tissue) in Groups I and TI, respectively (p=0.001). The lev
els of the perfusate MDA decreased and the levels of the perfusate GSH incr
eased significantly in the metoprolol group in the postreperfusion period i
n comparison with the preischemia term (p=0.003 and p=0.03, respectively).
Metoprolol reduces ischemic injury via prevention of lipid peroxidation and
reduces the myocardial energy demand by decreasing the heart rate.